|
Inhibition of factor xa : a potential target for the development of new anticoagulants.
Am J Cardiovasc Drugs. 2005 Ene; 5(5):279-90.
Alexander JH, Singh KP. |
|
Pregnancies and Oral Contraceptive Therapy in Severe (Homozygons) FXII Deficiency: A Study in 12 Patients and Review of the Literature.
J Thromb Thrombolysis. 2005 Ene; 18(3):209-12.
Girolami A, Zocca N, Girolami B, Lombardi AM, Fabris F. |
|
Factor VIII levels and the risk of pre-eclampsia, HELLP syndrome, pregnancy related hypertension and severe intrauterine growth retardation.
Thromb Res.. 2005 Ene; 115(5):387-92.
Witsenburg CP, Rosendaal FR, Middeldorp JM, Van der Meer FJ, Scherjon SA. |
|
Fondaparinux sodium : a review of its use in the treatment of acute venous thromboembolism.
Am J Cardiovasc Drugs. 2005 Ene; 5(5):335-46.
Robinson DM, Wellington K. |
|
ABO blood group genotypes and the risk of venous thrombosis: effect of factor V Leiden.
JThromb Haemost. 2005 Ene; 3(1):183-5.
Morelli VM, De Visser MC, Vos HL, Bertina RM, Rosendaal FR. |
|
Myocardial Infarction and Arterial Thrombosis in Severe (Homozygous) FXII Deficiency: No Apparent Causative Relation.
Clin App lThromb Hemost. 2005 Ene; 11(1):49-53.
Girolami A, Morello M, Girolami B, Lombardi AM, Bertolo C. |
|
Recurrent miscarriage syndrome and infertility due to blood coagulation protein/platelet defects: a review and update.
Clin Appl Thromb Hemost. 2005 Ene; 11(1):1-13.
Bick RL, Hoppensteadt D. |
|
FXIII polymorphisms, fibrin clot structure and thrombotic risk.
Biophys Chem. 2004 Dic; 112(2-3):223-8.
Kobbervig C, Williams E. |
|
Generic low-molecular-weight heparins: some practical considerations.
Semin Thromb Hemost. 2004 Dic; 30(6):703-13.
Fareed J, Leong WL, Hoppensteadt DA, Jeske WP, Walenga J, Wahi R, Bick RL. |
|
Combined use of rapid D-dimer testing and estimation of clinical probability in the diagnosis of deep vein thrombosis: systematic review.
BMJ. 2004 Oct; 329(7470):821-.
Fancher TL, White RH, Kravitz RL. |
|
Oral Antithrombins and the Future of Antithrombotic Therapy.
Rev Esp Cardiol. 2004 Oct; 57 (Supl. 1):2-8.
Fuster V. |
|
Recombinant activated factor VII in patients with cancer and hemorrhagic disseminated intravascular coagulation.
Blood Coagul Fibrinolysis.. 2004 Oct; 15(577):82-.
Sallah S, Husain A, Nguyen NP |
|
The impact of vitamin K-dependent factor depletion by warfarin on platelet-rich thrombosis after deep arterial injury.
J Thromb Haemost. 2004 Oct; 2(10):1834-41.
McBane RD 2nd, Hassinger NL, Grill DE, Chesebro JH. |
|
Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children.
N Engl J Med. 2004 Sep; 351(11):1081-8.
Goldenberg NA, Knapp-Clevenger R, Manco-Johnson MJ; Mountain States Regional Thrombophilia Group. |
|
Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Chest. 2004 Sep; 126(3 Suppl):483S-512S.
Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. |
|
Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Chest. 2004 Sep; 126(3 Suppl):429S-456S.
Singer DE, Albers GW, Dalen JE, Go AS, Halperin JL, Manning WJ. |
|
Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Chest. 2004 Sep; 126(3 Suppl):234S-264S.
Patrono C, Coller B, FitzGerald GA, Hirsh J, Roth G. |
|
Prothrombotic activity is increased in patients with nonvalvular atrial fibrillation and risk factors for embolism.
Chest. 2004 Sep; 126(3):687-92.
Inoue H, Nozawa T, Okumura K, Jong-Dae L, Shimizu A, Yano K. |
|
Preeclampsia and its interaction with common variants in thrombophilia genes.
J Thromb Haemost. 2004 Sep; 2(9):1588-93.
De Maat MP, Jansen MW, Hille ET, Vos HL, Bloemenkamp KW, Buitendijk S, Helmerhorst FM, Wladimiroff JW, Bertina RM, De Groot CJ. |
|
Antithrombotic therapy in valvular heart disease-native and prosthetic: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Chest. 2004 Sep; 126(3 Suppl):457S-482S.
Salem DN, Stein PD, Al-Ahmad A, Bussey HI, Horstkotte D, Miller N, Pauker SG. |
